Play all audios:
ABSTRACT In 2022, leukemia ranked as the second most common hematological malignancy after non-Hodgkin lymphoma worldwide. However, updated global estimates of leukemia incidence by subtype
are unavailable. We estimated leukemia incidences for different leukemia subtypes by country, world region, and human developmental index using data from the Cancer Incidence in Five
Continents databases combined with the GLOBOCAN 2022 estimates of leukemia in 185 countries. We estimated sex-specific age-standardized rates (ASRs) per 100 000 for children (0–19 years) and
adults (20+ years). In adults, the most common leukemia worldwide was AML (males: 38%, ASR = 3·1; females: 43%, ASR = 2·4), followed by CLL (males: 28%, ASR = 2·2; females: 24%, ASR = 1·3).
In very high HDI countries, the ASR of CLL was higher than the ASR of AML among males (5·2 versus 4·3, respectively) and similar among females (2·9 and 3·0, respectively). In children, the
most common leukemia was ALL (boys: 70%, ASR = 2·4; girls: 68%, ASR = 1·8) followed by AML (boys: 22%, ASR = 0·76; girls: 25%, ASR = 0·65). ALL proportions varied across world sub-regions
from 57 to 78% among boys, and from 49 to 80% among girls. Our findings suggest clear geographical patterns of leukemia subtypes in adults and children. Further research into underlying
causes that explain these variations is needed to support cancer control strategies for prevention and plan national healthcare needs. Access through your institution Buy or subscribe This
is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00
per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated
during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS GLOBAL BURDEN
OF HEMATOLOGIC MALIGNANCIES AND EVOLUTION PATTERNS OVER THE PAST 30 YEARS Article Open access 17 May 2023 INCIDENCE OF MYELOID NEOPLASMS IN SPAIN (2002–2013): A POPULATION-BASED STUDY OF THE
SPANISH NETWORK OF CANCER REGISTRIES Article Open access 10 January 2022 GLOBAL TRENDS AND BURDEN OF BRAIN AND CENTRAL NERVOUS SYSTEM CANCERS IN ADOLESCENTS AND YOUNG ADULTS GBD 2021 STUDY
Article Open access 16 May 2025 DATA AVAILABILITY The data used for the analyses are available from the Cancer Incidence in Five Countries databases and the GLOBOCAN 2022 database,
https://gco.iarc.fr/en. REFERENCES * Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024). Global cancer observatory: cancer today. Lyon, France: International Agency
for Research on Cancer. * Miranda-Filho A, Pineros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet
Haematol. 2018;5:e14–e24. Article PubMed Google Scholar * Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Doyla A, Bray F, et al. International incidence of childhood cancer,
2001-10: a population-based registry study. Lancet Oncol. 2017;18:719–31. Article PubMed PubMed Central Google Scholar * Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of
leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10:a034819. Article PubMed PubMed Central Google Scholar * Erdmann F, Kielkowski D, Schonfeld SJ, Kellett P, Stanulla M,
Dickens C, et al. Childhood cancer incidence patterns by race, sex and age for 2000-2006: a report from the South African National Cancer Registry. Int J Cancer. 2015;136:2628–39. Article
CAS PubMed Google Scholar * Lamb M, Painter D, Howell D, Barrans S, Cargo C, de Tute R, et al. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s
Haematological Malignancy Research Network. Cancer Epidemiol. 2024;88:102513. Article PubMed Google Scholar * Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al.
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116:3724–34. Article CAS PubMed Google Scholar * Marcos-Gragera R,
Galceran J, Martos C, de Munain AL, Vicente-Raneda M, Navarro C, et al. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl
Oncol. 2017;19:301–16. Article CAS PubMed Google Scholar * Solans M, Osca-Gelis G, Comas R, Roncero JM, Gallardo D, Marcos-Gragera R, et al. Challenges in assessing the real incidence of
chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer causes control : CCC. 2018;29:379–82. Article PubMed Google Scholar * Trallero
J, Sanvisens A, Almela Vich F, Jeghalef El Karoni N, Saez Lloret I. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European
context, 1983-2018. Front Oncol. 2023;13:1197850. Article PubMed PubMed Central Google Scholar * Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer
statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. * Bray F, Colombet M, Aitken JF, Bardot A, Eser S, Galceran
J, et al. (2023), Cancer Incidence in Five Continents, XII (IARC CancerBase No. 19). Lyon: International Agency for Research on Cancer. https://ci5.iarc.who.int. * UNDP. Human Development
Report 2020. _UNDP (United Nations Development Programme)_ 2020. * Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a
simulation-based analysis. Lancet Oncol. 2019;20:483–93. Article PubMed Google Scholar * Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type:
a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105:1684–92. Article CAS PubMed PubMed Central Google Scholar * Global Burden of Disease Cancer
Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with
disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553–68. Article Google
Scholar * Schmidt JA, Hornhardt S, Erdmann F, Sánchez-García I, Fischer U, Schüz J, et al. Risk factors for childhood leukemia: radiation and beyond. Front Public health. 2021;9:805757.
Article PubMed PubMed Central Google Scholar * Yang S, Varghese AM, Sood N, Chiattone C, Akinola NO, Huang X, et al. Ethnic and geographic diversity of chronic lymphocytic leukaemia.
Leukemia. 2021;35:433–9. Article PubMed Google Scholar * Zhao Y, Wang Y, Ma S. Racial differences in four leukemia subtypes: comprehensive descriptive epidemiology. Sci Rep. 2018;8:548.
Article PubMed PubMed Central Google Scholar * Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia. Lancet (Lond, Engl). 2018;391:1524–37. Article Google Scholar *
DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet (Lond, Engl). 2023;401:2073–86. Article CAS Google Scholar * Feurstein S, Drazer M, Godley LA. Germline
predisposition to hematopoietic malignancies. Hum Mol Genet. 2021;30:R225–r35. Article CAS PubMed Google Scholar * Eden T. Aetiology of childhood leukaemia. Cancer Treat Rev.
2010;36:286–97. Article CAS PubMed Google Scholar * Lim JY, Bhatia S, Robison LL, Yang JJ. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer.
2014;120:955–62. Article PubMed Google Scholar * Gupta S, Dai Y, Chen Z, Winestone LE, Teachey DT, Bona K, et al. Racial and ethnic disparities in childhood and young adult acute
lymphocytic leukaemia: secondary analyses of eight Children’s Oncology Group cohort trials. Lancet Haematol. 2023;10:e129–e41. Article CAS PubMed PubMed Central Google Scholar * Greaves
M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18:471–84. Article CAS PubMed PubMed Central Google Scholar * He JR, Ramakrishnan R, Hirst JE,
Bonaventure A, Francis SS, Paltiel O, et al. Maternal infection in pregnancy and childhood leukemia: a systematic review and meta-analysis. J Pediatr. 2020;217:98–109.e8. Article PubMed
Google Scholar * Bloom M, Maciaszek JL, Clark ME, Pui CH, Nichols KE. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev Hematol. 2020;13:55–70.
Article CAS PubMed Google Scholar * Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3):
analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (Lond, Engl). 2018;391:1023–75. Article
Google Scholar * WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: World Health Organization; 2020. * Bray F, Parkin DM. Cancer in sub-Saharan
Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 2022;23:719–28. Article PubMed Google Scholar Download references
ACKNOWLEDGEMENTS This study was supported by the International Agency for Research on Cancer / World Health Organization and the Faculty of Medicine, University of Bergen (PhD research
fellowship). We thank all the cancer registries who contributed data to the Cancer Incidence in Five Countries and/or GLOBOCAN 2022. FUNDING The work was funded by The International Agency
for Research on Cancer and the Faculty of Medicine, University of Bergen. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Cancer Surveillance Branch, International Agency for Research on
Cancer, Lyon, France Dagrun S. Daltveit, Eileen Morgan, Murielle Colombet, Eva Steliarova-Foucher & Isabelle Soerjomataram * Section for Epidemiology and Medical Statistics, Department
of Global Public Health and Primary Care, University of Bergen, Bergen, Norway Dagrun S. Daltveit * Casablanca Cancer Registry, Ibn Rochd Hospital, Casablanca, Morocco Karima Bendahhou *
CIBER Epidemiology and Public Health CIBERESP ISCIII, Madrid, Spain Rafael Marcos-Gragera * Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health,
Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI-CERCA), Josep Carreras Leukemia Research Institute, Girona, Spain Rafael
Marcos-Gragera * National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union
Medical College, Beijing, China Zheng Rongshou * Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK Alexandra Smith * Institute of
Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China Hui Wei Authors * Dagrun S. Daltveit View author publications You can also search for this
author inPubMed Google Scholar * Eileen Morgan View author publications You can also search for this author inPubMed Google Scholar * Murielle Colombet View author publications You can also
search for this author inPubMed Google Scholar * Eva Steliarova-Foucher View author publications You can also search for this author inPubMed Google Scholar * Karima Bendahhou View author
publications You can also search for this author inPubMed Google Scholar * Rafael Marcos-Gragera View author publications You can also search for this author inPubMed Google Scholar * Zheng
Rongshou View author publications You can also search for this author inPubMed Google Scholar * Alexandra Smith View author publications You can also search for this author inPubMed Google
Scholar * Hui Wei View author publications You can also search for this author inPubMed Google Scholar * Isabelle Soerjomataram View author publications You can also search for this author
inPubMed Google Scholar CONTRIBUTIONS IS, EM, and DSD designed and planned the study with support from AS. MC prepared the data. DSD performed the data analyses and wrote the first draft of
the manuscript with support from IS and EM. All authors had access to data, interpreted the results, revised the manuscript, and were responsible for the final decision to submit for
publication. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views
expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer / World Health Organization. CORRESPONDING
AUTHOR Correspondence to Dagrun S. Daltveit. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ETHICS APPROVAL AND CONSENT TO PARTICIPATE The study uses
anonymized and aggregated data publicly available in open-access repositories. Thus, ethical approval is not required. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral
with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTAL MATERIAL RIGHTS AND PERMISSIONS Springer Nature or its licensor
(e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted
manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Daltveit,
D.S., Morgan, E., Colombet, M. _et al._ Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022. _Leukemia_ 39, 412–419 (2025).
https://doi.org/10.1038/s41375-024-02452-y Download citation * Received: 27 September 2024 * Revised: 21 October 2024 * Accepted: 23 October 2024 * Published: 20 November 2024 * Issue Date:
February 2025 * DOI: https://doi.org/10.1038/s41375-024-02452-y SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a
shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative